GSK.LGSK.L
LOADING
|||
EPS Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
38.89%
↓ 56% below average
Average (39q)
88.50%
Historical baseline
Range
High:1189.67%
Low:-251.72%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 38.89% |
| Q2 2025 | -9.39% |
| Q1 2025 | 291.81% |
| Q4 2024 | 814.08% |
| Q3 2024 | -104.94% |
| Q2 2024 | 11.86% |
| Q1 2024 | 197.91% |
| Q4 2023 | -76.09% |
| Q3 2023 | -9.91% |
| Q2 2023 | 8.77% |
| Q1 2023 | -0.59% |
| Q4 2022 | -86.20% |
| Q3 2022 | 1189.67% |
| Q2 2022 | -53.60% |
| Q1 2022 | 92.08% |
| Q4 2021 | -19.89% |
| Q3 2021 | -16.33% |
| Q2 2021 | 29.75% |
| Q1 2021 | 58.09% |
| Q4 2020 | -45.60% |
| Q3 2020 | -45.06% |
| Q2 2020 | 44.26% |
| Q1 2020 | 20.20% |
| Q4 2019 | -16.33% |
| Q3 2019 | 60.84% |
| Q2 2019 | 15.89% |
| Q1 2019 | -31.91% |
| Q4 2018 | -14.37% |
| Q3 2018 | 220.44% |
| Q2 2018 | -19.64% |
| Q1 2018 | 200.00% |
| Q4 2017 | -145.16% |
| Q3 2017 | 771.00% |
| Q2 2017 | -117.27% |
| Q1 2017 | 304.08% |
| Q4 2016 | -68.10% |
| Q3 2016 | 288.64% |
| Q2 2016 | -251.72% |
| Q1 2016 | 179.23% |
| Q4 2015 | -165.36% |